Steward Partners Investment Advisory’s Aurinia Pharmaceuticals AUPH Stock Holding History

Steward Partners Investment Advisory’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-500	Closed	-$11K	–	3181
2021 Q3	$11K	Buy	+500	New	+$7.93K	﹤0.01%	2562
2021 Q2	–	Sell	-1,700	Closed	-$22.1K	–	7097
2021 Q1	$22.1K	Buy	+1,700	New	+$24.7K	﹤0.01%	2422
2020 Q2	–	Sell	-2,000	Closed	-$29K	–	2655
2020 Q1	$29K	Sell	2,000 -200	-9%	-$3.53K	﹤0.01%	1462
2019 Q4	$44K	Buy	2,200 +1,700	+340%	+$15.7K	﹤0.01%	1454
2019 Q3	$2K	Hold	500	–	–	﹤0.01%	2406
2019 Q2	$3K	Buy	+500	New	+$3.19K	﹤0.01%	2331
2018 Q4	–	Sell	-500	Closed	-$3K	–	865
2018 Q3	$3K	Hold	500	–	–	﹤0.01%	2259
2018 Q2	$3K	Hold	500	–	–	﹤0.01%	2106
2018 Q1	$2K	Buy	+500	New	+$2.67K	﹤0.01%	1986

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Steward Partners Investment Advisory's AUPH Position: Q4 2021 in Review

Steward Partners Investment Advisory sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2021, closing a stake of 500 shares — an estimated $11K sold.

Steward Partners Investment Advisory first reported a position in AUPH in Q1 2018 and held it in 9 quarters. The position peaked at $44K in Q4 2019. 190 funds tracked by Wall St. Rank hold AUPH as of Q4 2021.

Steward Partners Investment Advisory reported no remaining Aurinia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Steward Partners Investment Advisory sold 500 Aurinia Pharmaceuticals shares in Q4 2021, an estimated $11K.
Steward Partners Investment Advisory first reported a position in Aurinia Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Steward Partners Investment Advisory's Aurinia Pharmaceuticals position peaked at $44K in Q4 2019.
190 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2021, filed 8 Feb 2022.